Patent Assignment
Reel/Frame 052732/0776
Assignment of Assignor's Interest
Recorded: 2020-05-22
Pages: 4
Assignee
VISUS THERAPEUTICS, INC.
500 YALE AVENUE N, SEATTLE, WASHINGTON, 98112
Covered Properties
(4)
Using Parasympathomimetic Drugs Alone or, in Combination with One or More Alpha Agonists in Pseudophakic Patients, to Create Multi-Focality
Application:
62/963,891 →
Carabachol-Bromonidine Formulation to Enhance Antipresbyopia Effects
Application:
62/963,932 →
Using Parasympathomimetic Drugs Alone or, in Combination with One or More Alpha Agonists in Pseudophakic Patients, to Create Multi-Focality
Application:
62/970,155 →
Carabachol-Bromonidine Formulation to Enhance Antipresbyopia Effects
Application:
62/970,157 →
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 22, 2021
From: KAUFMAN, HERBERT E
To: VISUS THERAPEUTICS, INC.
Reel/Frame 055002/0731 →
Assignment of Assignor's Interest
Jan 22, 2021
From: SAMBURSKY, ROBERT P
To: VISUS THERAPEUTICS, INC.
Reel/Frame 055002/0981 →
Security Interest
Mar 20, 2024
From: VISUS THERAPEUTICS, INC.
To: LSP 6 HOLDING C.V., AS COLLATERAL AGENT
Reel/Frame 066839/0679 →
Release of Security Interest Reel 066839, Frame 0679
Dec 31, 2025
From: LSP 6 HOLDING C.V., AS COLLATERAL AGENT
To: VISUS THERAPEUTICS, INC.
Reel/Frame 074145/0450 →